NCT02767999View on ClinicalTrials.gov

Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Stroke
Interventions
DRUG

Fluoxetine

20 mg of fluoxetine capsule per day from D0 to D90

DRUG

Placebo

cellulose placebo per day from D0 to D90

RADIATION

fMRI

functional resting state MRI

Trial Locations (2)

31059

CHU Toulouse, Toulouse

Unknown

Hôpital Pellegrin, Bordeaux

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02767999 - Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter